LIGAND PHARMACEUTICALS INC 4
4 · LIGAND PHARMACEUTICALS INC · Filed May 26, 2004
Insider Transaction Report
Form 4
CROSS ALEXANDER D
Director
Transactions
- Sale
Common Stock
2004-05-26$20.00/sh−2,000$40,000→ 8,001 total(indirect: By Trust) - Sale
Common Stock
2004-05-25$19.00/sh−2,000$38,000→ 10,001 total(indirect: By Trust)
Holdings
- 24,494
Common Stock
Footnotes (1)
- [F1]Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 19, 2004.